VIEMED HEALTHCARE, INC. Repayments of Lines of Credit
VIEMED HEALTHCARE, INC. (VMD) reported Repayments of Lines of Credit of $5.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLinesOfCredit · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. repayments of lines of credit for the quarter ending 2026-06-30 was $2.18M, a 1937.38% increase year-over-year.
- VIEMED HEALTHCARE, INC. repayments of lines of credit for the quarter ending 2026-03-31 was $3.24M, a 2769.03% increase year-over-year.
- VIEMED HEALTHCARE, INC. repayments of lines of credit for the quarter ending 2025-12-31 was $8.00M.
- VIEMED HEALTHCARE, INC. repayments of lines of credit for the quarter ending 2025-09-30 was $4.78M, a 4.40% decline year-over-year.
- VIEMED HEALTHCARE, INC. repayments of lines of credit for fiscal 2025 was $13.00M, a 160.00% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. repayments of lines of credit for fiscal 2024 was $5.00M, a 28.62% decline from fiscal 2023.
- VIEMED HEALTHCARE, INC. repayments of lines of credit for fiscal 2023 was $7.00M.
- VIEMED HEALTHCARE, INC. repayments of lines of credit for fiscal 2022 was $0.00.
| Period end | Repayments of Lines of Credit 3 month | Repayments of Lines of Credit 6 month | Repayments of Lines of Credit 9 month | Repayments of Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $5.42M 10-Q · filed 2026-08-03 | $13.42M derived: sum of 3 quarters · filed 2026-08-03 | $18.20M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $3.24M 10-Q · filed 2026-05-05 | $11.24M derived: sum of 2 quarters · filed 2026-05-05 | $16.02M derived: sum of 3 quarters · filed 2026-05-05 | $16.13M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $12.78M derived: sum of 2 quarters · filed 2026-03-04 | $12.89M derived: sum of 3 quarters · filed 2026-08-03 | $13.00M 10-K · filed 2026-03-04 |
| 2025-09-30 | $4.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.89M derived: sum of 2 quarters · filed 2026-08-03 | $5.00M 10-Q · filed 2025-11-05 | $5.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $220.00K 10-Q · filed 2026-08-03 | $220.00K derived: sum of 3 quarters · filed 2026-08-03 | $5.22M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $113.00K 10-Q · filed 2026-05-05 | $113.00K derived: sum of 2 quarters · filed 2026-05-05 | $5.11M derived: sum of 3 quarters · filed 2026-05-05 | $4.52M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.00M derived: sum of 2 quarters · filed 2026-03-04 | $4.41M derived: sum of 3 quarters · filed 2026-03-04 | $5.00M 10-K · filed 2026-03-04 |
| 2024-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.41M derived: sum of 2 quarters · filed 2025-11-05 | $5.00M 10-Q · filed 2025-11-05 | $7.00M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | -$589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $2.00M derived: sum of 3 quarters · filed 2026-03-04 | $6.00M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $589.00K 10-Q · filed 2025-05-07 | $2.59M derived: sum of 2 quarters · filed 2026-03-04 | $6.59M derived: sum of 3 quarters · filed 2026-03-04 | $7.59M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $6.00M derived: sum of 2 quarters · filed 2026-03-04 | $7.00M derived: sum of 3 quarters · filed 2026-03-04 | $7.00M 10-K · filed 2026-03-04 |
| 2023-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $5.00M derived: sum of 2 quarters · filed 2024-11-06 | $5.00M 10-Q · filed 2024-11-06 | $5.00M derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.00M 10-Q · filed 2024-08-07 | $1.00M derived: sum of 3 quarters · filed 2025-03-10 | $133.00K derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | -$872.00K derived: sum of 3 quarters · filed 2025-03-10 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$872.00K derived: sum of 2 quarters · filed 2025-03-10 | $0.00 10-K · filed 2025-03-10 | |
| 2022-09-30 | -$872.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $872.00K 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |